ID
41467
Beschreibung
Study ID: 105043/013 Clinical Study ID: 105043/013 Study Title: An Open-Label Study of Argatroban Injection to Evaluate the Safety and Effectiveness in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin (Protocol SKF105043/013) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00039858 - See https://clinicaltrials.gov/ct2/show/NCT00039858 Sponsor: GlaxoSmithKline Collaborators: Encysive Pharmaceuticals Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Argatroban Trade Name: N/A Study Indication: Thrombosis This Study evaluates the safety and the efficacy of i.v. Argatroban treatment in paediatric patients which require anticoagulants but aren't suitable for Heparin treatment. The study consists of screening visit (pre-treatment examination), treatment period of maximum 14 days after reaching therapeutical dose, post-treatment visit (once the treatment is stopped or after 14 days) and a follow-up visit which follows 30 days (+/- 14 days) after clinical resolution of underlying condition or after the end of the 14-day study period. Treatment can be continued after the 14-day study period if needed but such treatment isn't part of this Study. The Transfusion Record has to be filled in whenever any bleeding occurs during the Study.
Link
https://clinicaltrials.gov/ct2/show/NCT00039858
Stichworte
Versionen (1)
- 20.10.20 20.10.20 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
20. Oktober 2020
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Safety and Efficacy of Argatroban in Pediatric Patients, NCT00039858
Transfusion Record
- StudyEvent: ODM
Beschreibung
Was a transfusion given during the Argatroban treatment period?
Alias
- UMLS CUI-1
- C1879316
- UMLS CUI-2
- C0347984
- UMLS CUI-3
- C0008976
Beschreibung
Transfusion Record
Alias
- UMLS CUI-1
- C1879316
Beschreibung
Blood component administered in transfusion
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0005841
- UMLS CUI [1,2]
- C1705248
Beschreibung
(dd-mmm-yyyy)
Datentyp
date
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C0808070
Beschreibung
(0000-2359)
Datentyp
time
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C1301880
Beschreibung
(dd-mmm-yyyy)
Datentyp
date
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C0806020
Beschreibung
(0000-2359)
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C1522314
Beschreibung
Quantity of transfusion
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1879316
- UMLS CUI [1,2]
- C1265611
Beschreibung
Units of transfusion quantity
Datentyp
text
Alias
- UMLS CUI [1,1]
- C1519795
- UMLS CUI [1,2]
- C1879316
- UMLS CUI [1,3]
- C1265611
Beschreibung
Reason for transfusion
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0392360
- UMLS CUI [1,2]
- C1879316
Ähnliche Modelle
Transfusion Record
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C2348184 (UMLS CUI [1,2])
C0347984 (UMLS CUI-2)
C0008976 (UMLS CUI-3)
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C1705248 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C1879316 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1879316 (UMLS CUI [1,2])